跳到主要内容
规管架构(B)专责小组

2021年会员

2022年提出的指控

监管框架(b)专责小组

的 mission of the 规管架构(B)专责小组 is to: 1) develop NAIC model acts and regulations for state health care initiatives; and 2) consider policy issues affecting state health insurance regulation.

对NAIC项目、产品和服务的持续支持

  1. 规管架构(B)专责小组 威尔:
    1. Coordinate and develop the provision of technical assistance to the states regarding state-level implementation issues raised by federal health legislation and regulations.
    2. 审查管理下的医疗改革, their delivery systems occurring in the marketplace and other forms of health care delivery. Recommend appropriate revisions to regulatory jurisdiction, authority and structures.
    3. Consider the development of new NAIC model laws and regulations and the revision of existing NAIC model laws and regulations, including those affected by federal legislation and final federal regulations promulgated pursuant to such legislation.
    4. Continue to review NAIC models recommended for revision by the former Affordable Care Act (ACA) Model Review (B) Working Group and, 适当的, appoint a working group or subgroup to revise the NAIC model(s) prioritized for revision in 2022.
    5. 按照健康保险和管理医疗(B)委员会的指示, through the work of the 雇员退休收入保障法(ERISA) (B)工作组, 监控, 分析和报告与协会健康计划相关的发展.
    6. 监控, 分析和报告, 必要时, 与短期有关的发展, 时间有限(STLD)报道.
  2. 事故和疾病保险最低标准(B)分组 威尔:
    1. 检查并考虑对 Model Regulation to Implement the Accident and Sickness Insurance Minimum Standards Model Act (#171).
  3. ERISA (B)工作组 威尔:
    1. 监控, 报告和分析与联邦ERISA相关的发展, and make recommendations regarding NAIC strategy and policy with respect to those developments.
    2. 监督、促进和协调各州和美国.S. 与虚假的健康计划有关.
    3. 监控, facilitate and coordinate with the states and the DOL regarding compliance and enforcement efforts regarding the ACA that relate to ERISA.
    4. 检查 Health and Welfare Plans Under the Employee Retirement Income Security Act: Guidelines for State and Federal Regulation (ERISA Handbook) and modify it, 必要时, to reflect developments related to ERISA. 每年的报告.
  4. 心理健康均等和成瘾平等法(B)工作组 威尔:
    1. 监控, report and analyze developments related to the federal Paul Wellstone and Pete Domenici MHPAEA of 2008, and make recommendations regarding NAIC strategy and policy with respect to those developments.
    2. 监控, facilitate and coordinate best practices with the states, the DOL and the U.S. 卫生与公众服务部(HHS)与MHPAEA有关.
    3. 监控, facilitate and coordinate with the states and the DOL regarding compliance and enforcement efforts regarding the ACA that relate to the MHPAEA.
    4. Provide supplemental resources to support documentation and reporting in the MHPAEA chapter of the NAIC Market Regulation Handbook.
    5. Coordinate with and provide input to 市场规管及消费者事务(D) Committee groups, 必要时, 关于心理健康平价市场进行检查.
  5. 药品福利经理监管问题(B)小组 威尔:
    1. 制定白皮书:1)分析和评估pbm的作用, 药剂服务行政机构, 以及其他供应链实体, play in the provision of prescription drug benefits; 2) identify, examine and describe current and emerging state regulatory approaches to PBM business practices, 比如价格透明度和报告要求, 折扣价和差价定价, 包括的影响 拉特里奇和. 药学服务管理协会(PCMA) decision on such business practices; and 3) discuss any challenges, 如果有任何, 各州在执行此类法律和/或法规时遇到的困难.
    2. Consider developing a new NAIC model to establish a licensing or registration process for pharmacy benefit managers (PBMs). 基于白皮书中确定的问题, the Subgroup may consider including in the new NAIC model provisions on PBM prescription drug pricing and cost transparency.

2021年修订采用收费

监管框架(b)专责小组

的 mission of the 规管架构(B)专责小组 is to: 1) develop NAIC model acts and regulations for state health care initiatives; and 2) consider policy issues affecting state health insurance regulation.

对NAIC项目、产品和服务的持续支持

  1. 规管架构(B)专责小组 威尔:
    1. Coordinate and develop the provision of technical assistance to the states regarding state-level implementation issues raised by federal health legislation and regulations.
    2. 审查管理下的医疗改革, their delivery systems occurring in the marketplace and other forms of health care delivery. Recommend appropriate revisions to regulatory jurisdiction, authority and structures.
    3. Consider the development of new NAIC model laws and regulations and the revision of existing NAIC model laws and regulations, including those affected by federal legislation and final federal regulations promulgated pursuant to such legislation.
    4. Continue to review NAIC models recommended for revision by the former Affordable Care Act (ACA) Model Review (B) Working Group and, 适当的, appoint a working group or subgroup to revise the NAIC model(s) prioritized for revision in 2021.
    5. 按照健康保险和管理医疗(B)委员会的指示, through the work of the 雇员退休收入保障法(ERISA) (B)工作组, 监控, 分析和报告与协会健康计划相关的发展.
    6. 监控, 分析和报告, 必要时, 与短期有关的发展, 时间有限(STLD)报道.
  2. 事故和疾病保险最低标准(B)分组 威尔:
    1. 检查并考虑对 Model Regulation to Implement the Accident and Sickness Insurance Minimum Standards Model Act (#171).
  3. ERISA (B)工作组 威尔:
    1. 监控, 报告和分析与联邦ERISA相关的发展, and make recommendations regarding NAIC strategy and policy with respect to those developments.
    2. 监督、促进和协调各州和美国.S. 与虚假的健康计划有关.
    3. 监控, facilitate and coordinate with the states and the DOL regarding compliance and enforcement efforts regarding the ACA that relate to ERISA.
    4. 检查 Health and Welfare Plans Under the Employee Retirement Income Security Act: Guidelines for State and Federal Regulation (ERISA Handbook) and modify it, 必要时, to reflect developments related to ERISA. 每年的报告.
  4. 心理健康均等和成瘾平等法(B)工作组 威尔:
    1. 监控, report and analyze developments related to the federal Paul Wellstone and Pete Domenici MHPAEA of 2008, and make  recommendations regarding NAIC strategy and policy with respect to those developments.
    2. 监控, facilitate and coordinate best practices with the states, the DOL and the U.S. 卫生与公众服务部(HHS)与MHPAEA有关.
    3. 监控, facilitate and coordinate with the states and the DOL regarding compliance and enforcement efforts regarding the ACA that relate to the MHPAEA.
    4. Provide supplemental resources to support documentation and reporting in the MHPAEA chapter of the NAIC Market Regulation Handbook.
    5. Coordinate with and provide input to 市场规管及消费者事务(D) Committee groups, 必要时, 关于心理健康平价市场进行检查.
  5. 药品福利经理监管问题(B)小组 威尔:
    1. Consider developing a new NAIC model to establish a licensing or registration process for pharmacy benefit managers (PBMs). 的 Subgroup may consider including in the new NAIC model provisions on PBM prescription drug pricing and cost transparency.
    2. 制定白皮书:1)分析和评估pbm的作用, 药剂服务行政机构, 以及其他供应链实体, play in the provision of prescription drug benefits; 2) identify, examine and describe current and emerging state regulatory approaches to PBM business practices, 比如价格透明度和报告要求, 折扣价和差价定价, 包括的影响 拉特里奇和. 药学服务管理协会(PCMA) decision on such business practices; and 3) discuss any challenges, 如果有任何, 各州在执行此类法律和/或法规时遇到的困难.  

NAIC支持人员:朱莉H. 马修斯/詹妮弗·R. 库克

监管框架TF 11月30日会议

公共Webex会议
2021年11月30日,星期二
东部时间下午12:30,ct时间上午11:30,mt时间上午10:30,pt时间上午9:30
预计通话时长:1小时
网讯链接

在秋季全国会议上以会议代替会议


监管框架工作组11月9日会议

公共Webex会议
2021年11月9日,星期二
东部时间晚上12点,东部时间上午11点,东部时间上午10点,东部时间上午9点
预计通话时长:1小时
网讯链接

考虑采纳2022年建议收费


监管框架工作组7月28日会议

公共Webex会议
2021年7月28日,星期三
东部时间上午11点,东部时间上午10点,东部时间上午9点,东部时间上午8点
预计通话时长:1小时
网讯链接

在夏季全国会议上以会议代替会议


监管框架工作组6月15日会议

公共Webex会议
2021年6月15日星期二
东部时间下午1点,东部时间下午12点,东部时间上午11点,东部时间上午10点
预计通话时长:1小时
网讯链接

Discuss and Consider for Adoption Proposed 2021 Charge for the PBM 监管机构y Issues (B) Subgroup to Draft White Paper


立法相关的出版物

联系人

媒体调查
(816) 783-8909
news@achibi.com


朱莉H. 马修斯
高级健康政策顾问 & 法律顾问
电话:

詹妮弗·R. 库克
高级卫生政策 & 立法分析师 & 法律顾问
电话:

请看电流 委员会名单 获取委员会成员的完整名单.